JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo
10th January 2024 Uncategorised 0 JPM24: BioMarin’s new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo
kdunleavy
Wed, 01/10/2024 – 11:11
More: JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo
Source: fierce
